Primera Management Team

Primera’s founding team has been working since 2021 with leading innovators in gene therapies including Mayo Clinic, Cellectis, and other key strategic partners, advisors and academic institutions. We have built a proven management, operational, and scientific team of internationally recognized leaders from biotech and pharma with successes in research and discovery, drug approvals, and commercial launches alongside key scientific and clinical thought leaders from the world-renowned Mayo Clinic.

By leveraging an innovative toolbox with the support of key strategic partners, Primera seeks to accelerate the development of mitochondrial disease therapies and rapidly support this undeserved patient population. Primera is working directly with Mayo Clinic, Cellectis, CHOP and other collaborators and parthers, to bring transformative therapeutics to clinic as fast as possible.